Name | Last modified | Size | Description | |
---|---|---|---|---|
Parent Directory | - | |||
Guidelines-For-Quali..> | 2024-11-15 10:54 | 375K | ||
Pharmacovigilance-In..> | 2024-11-15 10:33 | 384K | ||
Guidelines-for-Post-..> | 2018-06-12 13:49 | 440K | ||
Reviewed-NAFDAC-Good..> | 2024-04-23 08:26 | 480K | ||
NAFDAC-MAS-Guideline..> | 2022-05-13 10:45 | 545K | ||
NAFDAC-MAS-Guideline..> | 2018-12-28 14:03 | 1.0M | ||
Guidance-Manual-for-..> | 2024-11-21 14:09 | 1.0M | ||
NAFDAC-Guidelines-on..> | 2021-07-06 10:52 | 1.3M | ||
Nigerian-Guidelines-..> | 2024-11-21 14:12 | 1.6M | ||
NAFDAC-Guidelines-on..> | 2018-06-12 13:35 | 1.7M | ||
NAFDAC-Guidelines-On..> | 2021-01-25 10:02 | 1.7M | ||
Guidelines-For-UMC-R..> | 2024-11-15 10:57 | 2.2M | ||